Clindamycin Phosphate Injection

• • Cleocin injection, Pfizer, 150 mg/mL, 2 mL ADD-Vantage vial, 25 count, NDC 00009-6582-01
  • Cleocin injection, Pfizer, 150 mg/mL, 4 mL ADD-Vantage vial, 25 count, NDC 00009-3124-03
  • Cleocin injection, Pfizer, 150 mg/mL, 4 mL vial, 25 count, NDC 00009-0775-26
  • Cleocin injection, Pfizer, 150 mg/mL, 6 mL ADD-Vantage vial, 25 count, NDC 00009-3447-03
  • Cleocin injection, Pfizer, 300 mg/50 mL, in 5% dextrose premixed bag, 24 count, NDC 00009-3381-02
  • Cleocin injection, Pfizer, 600 mg/50 mL, in 5% dextrose premixed bag, 24 count, NDC 00009-3375-02
  • Cleocin injection, Pfizer, 900 mg/50 mL, in 5% dextrose premixed bag, 24 count, NDC 00009-3382-02
  • Clindamycin phosphate injection, Akorn, 900 mg/50 mL, premixed bottle, 1 count, NDC 17478-0122-50
  • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 2 mL ADD-Vantage vial, 25 count, NDC 47781-0462-69
  • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 2 mL ADD-Vantage vial, 25 count, NDC 47781-1619-69
  • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 4 mL ADD-Vantage vial, 25 count, NDC 44781-1620-69
  • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 4 mL ADD-Vantage vial, 25 count, NDC 44781-0463-69
  • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 6 mL ADD-Vantage vial, 25 count, NDC 47781-0464-69
  • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 6 mL ADD-Vantage vial, 25 count, NDC 47781-1621-69
  • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 6 mL vial, 25 count, NDC 44781-0461-68
  • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 60 mL vial, 1 count, NDC 63323-0282-60
  • Clindamycin phosphate injection, Sagent, 150 mg/mL, 60 mL bulk vial, 1 count, NDC 25021-0115-51

• • Akorn did not provide a reason for the shortage.
  • Alvogen did not provide a reason for the shortage.
  • Baxter has clindamycin injection available.
  • Fresenius Kabi did not provide a reason for the shortage.
  • Pfizer has Cleocin available.
  • Sagent had clindamycin on shortage due to manufacturing delays.
  • Sandoz has clindamycin injection available.

• • Cleocin injection, Pfizer, 150 mg/mL, 2 mL vial, 25 count, NDC 00009-0870-26
  • Cleocin injection, Pfizer, 150 mg/mL, 6 mL vial, 25 count, NDC 00009-0902-18
  • Cleocin injection, Pfizer, 150 mg/mL, 60 mL bulk vial, 5 count, NDC 00009-0728-09
  • Clindamycin phosphate injection, Akorn, 300 mg/50 mL, in 5% dextrose premixed bottle, 1 count, NDC 17478-0120-50
  • Clindamycin phosphate injection, Akorn, 600 mg/50 mL, premixed bottle, 1 count, NDC 17478-0121-50
  • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 2 mL vial, 25 count, NDC 47781-0459-68
  • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 4 mL vial, 25 count, NDC 47781-0460-68
  • Clindamycin phosphate injection, Alvogen, 150 mg/mL, 60 mL bulk vial, 1 count, NDC 47781-0465-70
  • Clindamycin phosphate injection, Baxter, 300 mg/50 mL, in 0.9% sodium chloride premixed container, 24 count, NDC 00338-9545-24
  • Clindamycin phosphate injection, Baxter, 300 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00338-3410-24
  • Clindamycin phosphate injection, Baxter, 600 mg/50 mL, in 0.9% sodium chloride premixed container, 24 count, NDC 00338-9549-24
  • Clindamycin phosphate injection, Baxter, 600 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00338-3612-24
  • Clindamycin phosphate injection, Baxter, 900 mg/50 mL, in 0.9% sodium chloride premixed container, 24 count, NDC 00338-9553-24
  • Clindamycin phosphate injection, Baxter, 900 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00338-3814-24
  • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 2 mL vial, 25 count, NDC 63323-0282-02
  • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 4 mL vial, 25 count, NDC 63323-0282-04
  • Clindamycin phosphate injection, Fresenius Kabi, 150 mg/mL, 6 mL vial, 25 count, NDC 63323-0282-06
  • Clindamycin phosphate injection, Sagent, 150 mg/mL, 2 mL vial, 25 count, NDC 25021-0115-02
  • Clindamycin phosphate injection, Sagent, 150 mg/mL, 4 mL vial, 25 count, NDC 25021-0115-04
  • Clindamycin phosphate injection, Sagent, 150 mg/mL, 6 mL vial, 25 count, NDC 25021-0115-06
  • Clindamycin phosphate injection, Sandoz, 300 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3288-09
  • Clindamycin phosphate injection, Sandoz, 600 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3289-09
  • Clindamycin phosphate injection, Sandoz, 900 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3290-09

Estimated Resupply Dates

• • Akorn has clindamycin 900 mg/50 mL in 5% dextrose premixes on back order and the company cannot estimate a release date.
  • Alvogen has clindamycin 150 mg/mL 2 mL, 4 mL, and 6 mL ADD-Vantage presentations on back order and the company cannot estimate a release date.
  • Pfizer has Cleocin 150 mg/mL 2 mL, 4 mL, and 6 mL ADD-Vantage vials on back order and the company estimates a release date of 2019. Cleocin 900 mg/50 mL in 5% dextrose premixed bags, and 600 mg/50 mL in 5% dextrose premixed bags are on back order and the company cannot estimate a release date. The 150 mg/mL 4 mL vials and 300 mg/50 mL in 5% dextrose premixed bags are available in limited supply.
  • Fresenius Kabi has clindamycin 150 mg/mL 60 mL vials available with an expiration date of <7 months.
  • Sagent has clindamycin 150 mg/mL 60 mL vials available with an expiration date of March 2019.